Ignite Creation Date:
2024-05-05 @ 9:36 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004081
Status:
COMPLETED
Last Update Posted:
2012-08-13
First Post:
1999-12-10
Brief Title:
Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer
Sponsor:
Beth Israel Deaconess Medical Center
Organization:
Dana-Farber Cancer Institute
Organization Data
Organization:
Dana-Farber Cancer Institute
Class:
OTHER
Study ID:
CDR0000067292
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Beth Israel Deaconess Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
Stephen Cannistra MD
Responsible Party Title:
Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Beth Israel Deaconess Medical Center
Old Name:
None
Old Organization:
None